Relevance of colony forming assays to bone marrow transplanation with particular reference to grafting for aplastic anaemia

British Journal of Haematology
M Y Gordon

Abstract

The value of bone marrow colony-forming assays in monitoring transplanted patients has been assessed by comparing results from two pairs of bone marrow recipients. One pair received marrow from their identical twins for acute lymphoblastic leukaemia; the other pair were grafted with allogeneic marrow from their siblings for aplastic anaemia. One of each pair showed successful engraftment while in the others the grafts failed. The colony-forming assay was then used to investigate marrow function in five grafted aplastic patients. Of these, four rejected their first grafts and required further immunosuppression before engraftment could be accomplished. The remaining patient was immunosuppressed at the outset with antithymocyte globulin (ATG) and her first graft was successful. Sera from all five patients inhibited colony formation by normal human marrow and it is suggested that this activity was related to graft rejection as well as to the pathogenesis of the condition.

References

Mar 10, 2005·Journal of Clinical Laboratory Analysis·Roger S RileyJonathan M Ben-Ezra
Oct 1, 1981·British Journal of Haematology·A J Barrett, J Adams
Feb 1, 1981·British Journal of Haematology·M Y Gordon, E C Gordon-Smith
Nov 1, 1987·International Journal of Cell Cloning·A Kanamaru, H Hara

Citations

Mar 27, 1976·Lancet·J AscensãoR Good
Jun 7, 1975·British Medical Journal·A J BarrettJ R Hobbs
Aug 1, 1978·British Journal of Haematology·M Y Gordon
Jan 1, 1978·Experimental Cell Research·M Y Gordon, I D Douglas

Related Concepts

Pathogenic Aspects
Aplastic Anemia
T-Lymphocyte
Pathogenesis
Decreased Immunologic Activity [PE]
Graft Acceptance
Bone Marrow
Graft Vs Host Reaction
PHGDH
Phosphoglycerate Dehydrogenase Activity

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.